Lv11
28 积分 2023-08-14 加入
Perioperative management of SGLT2 inhibitors: balancing euglycaemic ketoacidosis risk and cardiorenal benefits
12小时前
待确认
Mapping transcription factor functions in astrocytes using in vivo gain-of-function Perturb-seq
1个月前
已完结
Anaesthesia provider perspectives on well-being, work–life balance, and burnout prevention: a qualitative exploration
2个月前
已完结
Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users
2个月前
已完结
Perioperative dapagliflozin in diabetic patients undergoing cardiac surgery: the DAPA-CS trial
2个月前
已完结
Two Sides of a Coin: Safety Versus Harm of the ACC/AHA Perioperative Guideline Class 1 Level C-LD Recommendation for SGLT Discontinuation
3个月前
已完结
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
3个月前
已完结
Perioperative Management of Patients Receiving Sodium-Glucose Cotransporter 2 Inhibitors: Development of a Clinical Guideline at a Large Academic Medical Center
3个月前
已完结
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports
3个月前
已完结
A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes
3个月前
已完结
皖公网安备34019202002308
